As a French cluster, Lyonbiopole is the gateway to healthcare innovation in Auvergne-Rhône-Alpes. It aims at supporting ambitious projects and innovative companies in the healthcare & life sciences’ sector. It encourages innovators to develop new technologies, products and services toward a more personalized medicine and better treatments for patients. The cluster’s strategic missions are focused around:
- promoting the emergence of innovative R&D collaborative projects;
- supporting SME in areas such as strategic partnerships, access to private investors, expertise and training;
- fostering SME Internationalization and the cluster’s position at the European and International levels;
- offering access to high-level facilities dedicated to life sciences companies.
In 2018, Lyonbiopole represented a community of 226 members: 6 founding members (Sanofi Pasteur, bioMérieux, Boehringer Ingelheim Animal Health, Becton Dickinson, CEA and Fondation Merieux), 202 innovative companies mainly SMEs and 18 Research Centers. Lyonbiopole received the European cluster excellence “Gold Label” by ECEI for 2nd time in 2017 and is HealthTech advisor within the French Tech network.